BONU Stock | News | Quote | Stock Forum | Friday, December 13,

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
$BONU BioNeutral Group, Inc. BONU Company Overview 

BioNeutral Group, Inc. BONU Current Price and Quotes
Last Price 0.0015
Previous Close 0.0016 Open 0.0012
Daily Range 0.002 - 0.0012 52wk Range 0.0999 - 0.0004
Volume 95,269,572 Dividend N/A
Average Vol (3m) 15,232,422 Yield N/A

BONU Stock Message Board http://investorshangout.com/search?q=BONU&...mp;yt1=Go!

Last Updated: Friday, December 13, 2013 01:43:58 AM

BioNeutral Group, Inc. BONU
Company Information

211 Warren St.
Newark, NJ 07103

Website: http://www.bioneutral.com
Phone: 973-577-8003
Email: info@bioneutral.com

BioNeutral Group, Inc. BONU
BioNeutral Group, Inc. BONU
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report Jul 31, 2013 10-Q
CIK 0001427030
Fiscal Year End 10/31
OTC Marketplace OTCQB
Profile Data

SIC - Industry Classification 2810 - Industrial Inorganic Chemicals
Business Status Development Stage Company a/o Apr 30, 2008
Incorporated In: NV, USA
Year of Inc. 2007
Employees Not Available
Company Officers/Contacts

Andy Kielbania Interim CEO
Dr. Andy Kielbania Chief Scientist
Company Directors

Stephen Holt Vice Chairman
Michael D. Francis
Andy Kielbania
Mark Lowenthal
Raj Pamani
Wayne Stratton
Company Notes

Formerly=Moonshine Creations, Inc. until 1-2009
Service Providers

Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Corporate Evolutions, Inc.
111 Great Neck Road
Great Neck, NY, 11021
United States


BioNeutral Group, Inc. BONU
BONU Security Details

Share Structure

Market Value1 $691,484 a/o Dec 12, 2013
Shares Outstanding 460,989,458 a/o Dec 10, 2013
Float Not Available
Authorized Shares Not Available
Par Value  0.00001
Shareholders

Shareholders of Record 150 a/o Feb 10, 2012
Security Notes

Capital Change=shs increased by 30 for 1 split. Payable upon surrender.. Pay date=01/20/2009.
Short Selling Data

Short Interest 0 (-100%)
Nov 29, 2013
Significant Failures to Deliver  No
Transfer Agent(s)

Corporate Stock Transfer, Inc.

BioNeutral Group, Inc. BONU Financials
Period Ending Oct 31, 2012 Oct 31, 2011 Oct 31, 2010 Oct 31, 2009
Total Revenue 5 54 16 3
Cost of Revenue 2 21 12 6
Gross Profit 2 33 3 (3)
Operating Expenses

Research and Development - - 265 -
Sales, General and Admin. 1,550 1,682 1,564 14,968
Non-Recurring Items 284 548 1,224 -
Other 709 707 697 627
Operating Income (2,540) (2,904) (3,746) (15,599)
Income From Continuing Operations

Add'l Income/Expense Items - - - 4
Earnings Before Interest and Tax (2,540) (2,904) (3,746) (15,595)
Interest Expense 66 156 87 3
Earnings Before Tax (2,606) (3,061) (3,833) (15,598)
Income Tax - - - -
Minority Interest (220) (242) (332) (2,147)
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (2,386) (2,819) (3,502) (13,451)
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (2,386) (2,819) (3,502) (13,451)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (2,386) (2,819) (3,502) (13,451)

BioNeutral Group, Inc. BONU Recent News

Dec 12, 2013 BioNeutral Announces U.S. Distribution Agreement With BioTech Medical


BONU BioNeutral Group, Inc. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=BONU&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/BONU/quote
Stock Chart http://www.otcmarkets.com/stock/BONU/chart
Company Info http://www.otcmarkets.com/stock/BONU/company-info
Recent News http://www.otcmarkets.com/stock/BONU/news
Financials http://www.otcmarkets.com/stock/BONU/financials
Filings and Disclosure http://www.otcmarkets.com/stock/BONU/filings
Short Sales http://www.otcmarkets.com/stock/BONU/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/BONU/insider-transactions
Research Reports http://www.otcmarkets.com/stock/BONU/research
Summary http://finance.yahoo.com/q?s=BONU
Historical Prices http://finance.yahoo.com/q/hp?s=BONU+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=BONU
Basic Chart http://finance.yahoo.com/q/bc?s=BONU+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=BONU+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=BONU+Headlines
Press Releases http://finance.yahoo.com/q/p?s=BONU+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=BONU+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=BONU+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=BONU+Industry
Major Holders http://finance.yahoo.com/q/mh?s=BONU+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=BONU+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=BONU+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=BONU
Balance Sheet http://finance.yahoo.com/q/bs?s=BONU
Cash Flow http://finance.yahoo.com/q/cf?s=BONU+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/BONU
Market Watch http://www.marketwatch.com/investing/stock/BONU
Bloomberg http://www.bloomberg.com/quote/BONU:US
Morningstar http://quotes.morningstar.com/stock/s?t=BONU
Bussinessweek http://investing.businessweek.com/research/st...icker=BONU
Barchart http://www.barchart.com/quotes/stocks/BONU
OTC Short Report http://otcshortreport.com/index.php?index=BONU
Investopedia http://www.investopedia.com/markets/stocks/BONU/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 255

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 266

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Princess Cruises Launches New Era at Celebration Key

Updated Category News Views 185

Never thought I'd see the day when a cruise ship docking would stir such excitement, but here we are. The Star Princess has made its grand debut at Celebration Key, the latest jewel in Princess Cruises' crown. And they're going all out with Bahamian flair—something about a Junkanoo band and beach art that would make even the crustiest sailor crack a smile. Inaugural Fun...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 176

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 210

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 113

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 251

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 115

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 119

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 59

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading

Top 5 Most Recently Viewed Articles

Flora Growth Corp Sees 6% Surge in After-Hours Performance

Updated Category News Views 87

A Surge in After-Hours Trading for Flora Growth Corp Flora Growth Corp. (NASDAQ: FLGC) recently demonstrated significant volatility by surging 5.98% to $10.55 during after-hours trading. This movement came not long after closing at $9.96, which marked an increase of 3.59% earlier that day. Insights from Recent SEC Filing Regulation A Filing In a notable move, Flora Growth...

Continue Reading
Qubs Introduces Qubitunes, A New Interactive Audio Experience

Updated Category News Views 205

Qubs Launches Qubitunes for Creative Play Qubs has unveiled an exciting new product, Qubitunes, which has already won the 'Top Toy' award in the startup category at a prestigious Toy Fair. This innovative toy is set to transform playtime for children by offering a unique platform where they can express their creativity and dive into their own audio storytelling...

Continue Reading
Asyad Group's Expert Transport of Heavy Cryogenic Tank

Updated Category News Views 126

Asyad Group's Successful Transport of Cryogenic Tank Asyad Group has recently completed a remarkable international transport operation, successfully moving a 115 metric ton pressurized cryogenic tank from Northern India to a major destination in Saudi Arabia. This endeavor highlights the Group's expertise in cross-border logistics. A Journey of Precision The transport...

Continue Reading
Famous Toastery Launches Holiday Fundraising Efforts

Updated Category News Views 134

Famous Toastery's Compassionate Campaign for Local Communities The Famous Toastery, known for its delightful breakfast and brunch offerings, is stepping up this holiday season with a noble initiative aimed at fighting hunger. This renowned franchise is collaborating with Feeding the Carolinas, encouraging guests to make donations that will significantly impact individuals...

Continue Reading
Jiayin Group's Upcoming Earnings Call Set for November 25, 2025

Updated Category News Views 190

Jiayin Group Inc. Announces Q3 2025 Financial Results Release Jiayin Group Inc. (NASDAQ: JFIN), a prominent fintech platform in China, has shared significant news that it will unveil its unaudited financial outcomes for the third quarter of 2025. This crucial announcement is set to occur before the U.S. markets open on November 25, 2025. The anticipation surrounding these...

Continue Reading